Search - tctmd.com

Displaying 421 - 440 of 509

Sort: Relevancy | Date

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation

Impact of Coronary Lesion Complexity on DES Outcomes in Patients with and Without Diabetes

Presenter: E. Kedhi

March 12, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation TCT 2013

Pro Position: FREEDOM was the Final Nail in the Coffin!

Presenter: Duane Pinto

October 31, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

Presentation TCT 2013

Incretin-Based Therapy: Emerging Evidence for a Better Path to Glycemic Control

Presenter: Michael Farkouh

October 30, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: CABG for All!

Presenter: Craig Smith

October 30, 2013

Presentation TCT 2013

Concluding Case: A 62 year Old diabetic Patient with STEMI

Presenter: Vladimir Dzavik

October 30, 2013

Presentation TCT 2013

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

Presenter: Vasim Farooq

October 30, 2013

Presentation TCT 2013

The Glucometabolic Milieu: Implications on Platelet Function in the PCI Patient

Presenter: Frederick Feit

October 30, 2013

Presentation TCT 2013

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Presenter: Marco Wainstein

October 30, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Presenter: Kevin Beatt

October 30, 2013

Presentation TCT 2013

FREEDOM: Essential results

Presenter: Michael Farkouh

October 27, 2013

Presentation

Quality of Life after PCI vs. CABG Among Patients with Diabetes and Multivessel CAD

Presenter: M.S. Abdallah

October 15, 2013

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

高风险亚组从瑞舒伐他汀中获得肾脏保护

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Advertisement

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Impact of Coronary Lesion Complexity on DES Outcomes in Patients with and Without Diabetes

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Pro Position: FREEDOM was the Final Nail in the Coffin!

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Incretin-Based Therapy: Emerging Evidence for a Better Path to Glycemic Control

Diabetes Mellitus and Multivessel Disease: CABG for All!

Concluding Case: A 62 year Old diabetic Patient with STEMI

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

The Glucometabolic Milieu: Implications on Platelet Function in the PCI Patient

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

FREEDOM: Essential results

Quality of Life after PCI vs. CABG Among Patients with Diabetes and Multivessel CAD

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

高风险亚组从瑞舒伐他汀中获得肾脏保护

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content